All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug substance production at Moderna's new facility in Laval, Quebec, and fill-finish ...

Moderna is working with advanced technology to help transform the way medicines are created, but is that enough reason to stick around?

UBS Group lowered their price objective on shares of Moderna from $78.00 to $70.00 and set a “buy” rating on the stock in a research report on Friday, May 2nd.

Shares in drug giant Moderna ($MRNA) were over 5% healthier today after Canada said yes to its Covid vaccine. Health Canada said it had given the ...

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Moderna, Inc. (NASDAQ:MRNA) is ...

Analysts expect Moderna to post earnings of ($2.90) per share and revenue of $130.35 million for the quarter. Moderna Price Performance Shares of Moderna stock opened at $27.46 on Tuesday.

As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

The recent 11% drop in Moderna, Inc.'s (NASDAQ:MRNA) stock could come as a blow to insiders who purchased US$6.01m worth of ...

Key Points Moderna has struggled since COVID-19 vaccine demand has shrunk. The stock has correspondingly declined, as revenue has nosedived over the last few years. The long game is clinical ...

For our part, Moderna has joined our watchlist of discarded, beaten-up, and unloved firms. In the quarters and years ahead, ...

MRNA Price Action: At the time of writing, Moderna stock is trading 2.73% higher at $27.28, according to data from Benzinga Pro. Image: Shutterstock.